Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Morgan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilitiesSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibitionSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2008
Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonistsSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytesD L Crandall, E M Quinet, G A Morgan, et al.
Experimental Gerontology|April 29, 2018
Proteomic analysis of age-related changes in ovine cerebrospinal fluidCarl P C Chen, Jane E Preston, Shaobo Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonistsFabrizio Giordanetto, Olle Karlsson, Jan Lindberg, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 8, 2004
Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activityAnnika Astrand, Mohammad Bohlooly-Y, Sara Larsdotter, et al.
Journal of Thrombosis and Haemostasis : JTH|July 16, 2008
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosisJ K Hennan, G A Morgan, R E Swillo, et al.
The Journal of Eukaryotic Microbiology|March 1, 1994
African buffalo serum contains novel trypanocidal proteinD Reduth, J G Grootenhuis, R O Olubayo, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 9, 2009
Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in miceEmil Egecioglu, Karolina Ploj, Xiufeng Xu, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilitiesSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibitionSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2008
Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonistsSusanne Berglund, Bryan J Egner, Henrik Gradén, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytesD L Crandall, E M Quinet, G A Morgan, et al.
Experimental Gerontology|April 29, 2018
Proteomic analysis of age-related changes in ovine cerebrospinal fluidCarl P C Chen, Jane E Preston, Shaobo Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonistsFabrizio Giordanetto, Olle Karlsson, Jan Lindberg, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 8, 2004
Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activityAnnika Astrand, Mohammad Bohlooly-Y, Sara Larsdotter, et al.
Journal of Thrombosis and Haemostasis : JTH|July 16, 2008
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosisJ K Hennan, G A Morgan, R E Swillo, et al.
The Journal of Eukaryotic Microbiology|March 1, 1994
African buffalo serum contains novel trypanocidal proteinD Reduth, J G Grootenhuis, R O Olubayo, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 9, 2009
Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in miceEmil Egecioglu, Karolina Ploj, Xiufeng Xu, et al.
Pageof 7